Geoff I. Simon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Geoff I. Simon has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alison Craswell
School of Health, University of the Sunshine Coast, Sippy Downs, Qld, Australia
4 shared publications - Yoke Lin Fung
Critical Care Research Group, University of Queensland and the Prince Charles Hospital, Brisbane, Australia
4 shared publications - Ogilvie Thom
College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Australia
3 shared publications Ogilvie Thom
Department of Emergency Medicine Sunshine Coast University Hospital, Sunshine Coast Hospital and Health Service Sunshine Coast Queensland Australia
2 shared publicationsAlison Craswell
School of Nursing, Midwifery and Paramedicine University of the Sunshine Coast Sunshine Coast Queensland Australia
1 shared publicationChris M Anstey
Intensive Care Unit, Sunshine Coast University Hospital, Sunshine Coast Hospital and Health Service; School of Medicine, University of Queensland; School of Medicine, Griffith University, Birtinya, Australia
1 shared publication
Latest Publications
- 26 September 2021
- Published by Wiley in Emergency Medicine Australasia
- Vol. 34 (2) , 244-251
Unplanned blood use within 24 hours of emergency department presentation: A cohort study in an ageing population
Objective This research aims to elucidate drivers of blood use in an older population, with a focus on unplanned transfusions following ED presentation. Methods In a retrospective cohort study we examined 2015 data for ED presentations and blood use in two hospitals serving a population containing a high proportion (21%) of adults aged ≥65 years. Unplanned blood use was defined as any transfusion ≤24 h of presentation. Data were analysed by age, sex, Major Diagnostic Category, triage category and time to transfusion. Results A total of 5294 blood components were transfused, comprising red cells (n = 3784), fresh frozen plasma (n = 657), platelets (n = 563) and cryoprecipitate (n = 290). Men aged ≥65 years were the highest users (40%, 2107 components). Unplanned transfusions accounted for 28% (n = 1057) of annual red cell use. Of 85 014 ED presentations, 494 (0.6%) were associated with unplanned red cell transfusion. Four Major Diagnostic Categories accounted for 81% (n = 853) of unplanned red cell use: gastrointestinal (n = 375), haematology (n = 267), trauma (n = 144) and cardiovascular (n = 67). Over one-fifth of unplanned transfusions (21%, n = 222 of 1057) were associated with ICD-10 codes for anaemia as a reason for presentation within the Haematology Major Diagnostic Category. Adults aged ≥65 years accounted for 62% of overall red cell use and 61% of transfusions ≤24 h of presentation. Odds of unplanned red cell transfusion increased with age, peaking at odds ratio 28.5 (95% confidence interval 14.2–57.4) in those aged 85 years and above. Conclusions Unplanned blood use accounted for 28% of annual hospital blood consumption. Blood component use increased with age and was greatest in older men. A significant burden of anaemia treatment was identified by the ED.
- 26 September 2021
- Published by Wiley in Emergency Medicine Australasia
- Vol. 34 (2) , 244-251
Unplanned blood use within 24 hours of emergency department presentation: A cohort study in an ageing population
Objective This research aims to elucidate drivers of blood use in an older population, with a focus on unplanned transfusions following ED presentation. Methods In a retrospective cohort study we examined 2015 data for ED presentations and blood use in two hospitals serving a population containing a high proportion (21%) of adults aged ≥65 years. Unplanned blood use was defined as any transfusion ≤24 h of presentation. Data were analysed by age, sex, Major Diagnostic Category, triage category and time to transfusion. Results A total of 5294 blood components were transfused, comprising red cells (n = 3784), fresh frozen plasma (n = 657), platelets (n = 563) and cryoprecipitate (n = 290). Men aged ≥65 years were the highest users (40%, 2107 components). Unplanned transfusions accounted for 28% (n = 1057) of annual red cell use. Of 85 014 ED presentations, 494 (0.6%) were associated with unplanned red cell transfusion. Four Major Diagnostic Categories accounted for 81% (n = 853) of unplanned red cell use: gastrointestinal (n = 375), haematology (n = 267), trauma (n = 144) and cardiovascular (n = 67). Over one-fifth of unplanned transfusions (21%, n = 222 of 1057) were associated with ICD-10 codes for anaemia as a reason for presentation within the Haematology Major Diagnostic Category. Adults aged ≥65 years accounted for 62% of overall red cell use and 61% of transfusions ≤24 h of presentation. Odds of unplanned red cell transfusion increased with age, peaking at odds ratio 28.5 (95% confidence interval 14.2–57.4) in those aged 85 years and above. Conclusions Unplanned blood use accounted for 28% of annual hospital blood consumption. Blood component use increased with age and was greatest in older men. A significant burden of anaemia treatment was identified by the ED.
- 1 July 2019
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 33 (3) , 154-161
Impacts of Aging on Anemia Tolerance, Transfusion Thresholds, and Patient Blood Management
- 1 July 2019
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 33 (3) , 154-161
Impacts of Aging on Anemia Tolerance, Transfusion Thresholds, and Patient Blood Management
- 7 September 2018
- Published by Wiley in ISBT Science Series
- Vol. 14 (1) , 58-66
Questioning the benefit of restrictive transfusion practice in older adults
Restrictive transfusion practice is widely promoted, with many international guidelines recommending haemoglobin thresholds of 70 to 80 g/l for adult patients who are asymptomatic. Randomized controlled trials comparing outcomes associated with liberal and restrictive transfusion strategies underpin this approach. Meta‐analyses including trials of adult patients >18 years of age have concluded that restrictive practice is noninferior to liberal transfusion approaches. A restrictive approach to transfusion reduces resource consumption and cost, as well as the hazards associated with unnecessary exposure to blood products. Although adults aged ≥65 years consume over half of the blood supply, there are few randomized controlled transfusion trials exclusive to this cohort. Our 2017 meta‐analysis of a small number of trials focussed on older adults found that higher transfusion haemoglobin thresholds were associated with lower mortality and fewer cardiac complications in this age group. Other studies have also shown that higher transfusion haemoglobin thresholds are beneficial in older adults. This paper presents recent evidence regarding transfusion outcomes in older adults and discusses aspects of the pathophysiology of ageing that impact on the reduced resilience of older patients to anaemic states. This evidence challenges the use of Hb thresholds that apply across the adult lifespan, regardless of age. It proposes that older age be considered as a risk factor in assessing transfusion requirements, and that transfusion practice in older adults may require higher haemoglobin thresholds than for younger adults.
- 7 September 2018
- Published by Wiley in ISBT Science Series
- Vol. 14 (1) , 58-66
Questioning the benefit of restrictive transfusion practice in older adults
Restrictive transfusion practice is widely promoted, with many international guidelines recommending haemoglobin thresholds of 70 to 80 g/l for adult patients who are asymptomatic. Randomized controlled trials comparing outcomes associated with liberal and restrictive transfusion strategies underpin this approach. Meta‐analyses including trials of adult patients >18 years of age have concluded that restrictive practice is noninferior to liberal transfusion approaches. A restrictive approach to transfusion reduces resource consumption and cost, as well as the hazards associated with unnecessary exposure to blood products. Although adults aged ≥65 years consume over half of the blood supply, there are few randomized controlled transfusion trials exclusive to this cohort. Our 2017 meta‐analysis of a small number of trials focussed on older adults found that higher transfusion haemoglobin thresholds were associated with lower mortality and fewer cardiac complications in this age group. Other studies have also shown that higher transfusion haemoglobin thresholds are beneficial in older adults. This paper presents recent evidence regarding transfusion outcomes in older adults and discusses aspects of the pathophysiology of ageing that impact on the reduced resilience of older patients to anaemic states. This evidence challenges the use of Hb thresholds that apply across the adult lifespan, regardless of age. It proposes that older age be considered as a risk factor in assessing transfusion requirements, and that transfusion practice in older adults may require higher haemoglobin thresholds than for younger adults.
- 1 October 2017
- Published by Elsevier in The Lancet Haematology
- Vol. 4 (10) , e465-e474
Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis
- 1 October 2017
- Published by Elsevier in The Lancet Haematology
- Vol. 4 (10) , e465-e474
Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis
- 11 September 2017
- Published by Elsevier in The Lancet Haematology
- Vol. 4 (11) , e508
Authors' reply to comment Blood transfusion strategies in elderly patients
- 11 September 2017
- Published by Elsevier in The Lancet Haematology
- Vol. 4 (11) , e508
Authors' reply to comment Blood transfusion strategies in elderly patients